• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

GAiT.Global

The Global Alliance for iPSC Therapies

  • About GAiT
    • About GAiT
    • Sponsors
      • NYSCF
      • KHiB
      • CCRM
      • INSERM / Cithera /INGESTEM
      • HKU
      • CGT
    • Support Us
  • News & Events
  • Publications
  • Workshops
  • iPSC Quality Assessment Rounds
    • iPSC Quality Assessment Round 2022/2023
      • iPSC Quality Assessment Round 2022 – Document Page
  • Directories
  • Clinical Database
  • Portal Login
You are here: Home / Board Members / CGT

CGT

cgt

A centre of excellence

The Cell and Gene Therapy Catapult is a centre of excellence in innovation, with the core purpose of building a world-leading cell and gene therapy sector in the UK as a key part of a global industry. Supported by Innovate UK, our mission is to drive the growth of the industry by helping cell and gene therapy organisations across the world translate early stage research into commercially viable and investable therapies. We are based on the 12th floor of Guy’s Hospital in central London, with over 120 cell and gene therapy experts, state-of-the art development and viral vector laboratories. We are also building a £55m large-scale GMP manufacturing centre to help bring cell and gene therapies to market in the UK and internationally.

Our vision

The Cell and Gene Therapy Catapult vision is for the UK to be a global leader in the development, delivery and commercialisation of cell and gene therapy. Where businesses can start, grow and confidently develop cell and gene therapies, delivering them to patients rapidly, efficiently and effectively.

Our mission

Our mission is to grow the industry in the UK to substantial and sustainable levels by:

  • taking products into clinical trial, de-risking them for further investment;
  • providing clinical expertise and access to NHS clinical partners;
  • providing technical expertise and infrastructure to ensure products can be made to GMP and delivered cost effectively;
  • providing regulatory expertise to ensure that products can get to the clinic safely, in the shortest amount of time;
  • providing opportunities for collaboration, both nationally and globally; and
  • providing access to business expertise, grants and investment finance so that commercially viable products are progressed and investable propositions are generated.

Primary Sidebar

Search Users

GAiT News

Find us on Twitter
IPSCtherapies avatar; GAiT @IPSCtherapies ·
15 Dec 1603361474143035396

GAiT joins CCRM on their latest podcast to discuss the clinical potential of induced Pluripotent Stem Cells

Image for twitter card

‎Commercializing Living Therapies with CCRM: Unlocking the potential of induced pluripotent stem...

‎Show Commercializing Living Therapies with CCRM, Ep Unlocking the potential of induced pluripotent stem cells - Dec 14, 2022

podcasts.apple.com

Reply on Twitter 1603361474143035396 Retweet on Twitter 1603361474143035396 0 Like on Twitter 1603361474143035396 0 Twitter 1603361474143035396
IPSCtherapies avatar; GAiT @IPSCtherapies ·
22 Aug 1561763439541981184

https://advancedtherapiesweek.phacilitate.com/

Image for the Tweet beginning:  Twitter feed image.
Reply on Twitter 1561763439541981184 Retweet on Twitter 1561763439541981184 0 Like on Twitter 1561763439541981184 1 Twitter 1561763439541981184
IPSCtherapies avatar; GAiT @IPSCtherapies ·
22 Aug 1561760752645672960

GAiT looks forward to speaking to Indian Colleagues from CMC Vellore at the 7th Cell and Gene Therapy Symposium 1st -3rd September 2022. http://www.cscr.res.in/symposium

Reply on Twitter 1561760752645672960 Retweet on Twitter 1561760752645672960 0 Like on Twitter 1561760752645672960 1 Twitter 1561760752645672960
Load More...

Invite Users to Site

Invite another user onto the GAiT Website
Invite Users

Social media

Follow us on social media

GAiT LinkedIn GAit Sound Cloud GAiT Twitter

 

 

Newsletter





© 2023 GAiT. All Rights reserved. Web Design by Conceptstore
  • Home
  • Portal Login